Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)

Abbott

Status

Completed

Conditions

Bradycardia

Treatments

Device: Intervention/treatment

Study type

Interventional

Funder types

Industry

Identifiers

NCT00311168

CRD343

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.

Enrollment

135 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient has been implanted with dual chamber SJM Victory® device with VIP™ for 1 month (± 2 weeks).
At the time of pacemaker implant, VIP™ is programmed "OFF".
At the time of enrollment, patient is paced in the RV ≤ 60% of the time.
Patient is medically stable.

Exclusion criteria

Patient has evidence of complete AV block, such that ventricular pacing would be required as part of the patient's routine management.
Patient is indicated for AF Suppression.
Patient has persistent or chronic atrial fibrillation.
Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.
Patient is currently participating in another device research study.
Patient is younger than 18 years of age.
Patient is pregnant.
Patients life expectancy is less than 12 months.